Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

January 3, 2024 Only FDA-Approved As-Needed Treatment For The Approximately 6…


Cosette Pharmaceuticals Appoints Ted Smolenski as Vice President of Portfolio & Business Development

Experienced business development executive to accelerate Cosette’s growth…


Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable

Online Pharmacy to Offer Proven Fertility Medication at Low Cost BRIDGEWATER,…


Metronidazole Vaginal Gel

Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%

Further expands Cosette’s portfolio in affordable women’s healthcare…


Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.

Acquisition accelerates Cosette’s women’s health portfolio; with a…


Jackie Beltrani Joins Cosette Pharmaceuticals as Director, Commercial Operations.

We are pleased to announce that Jackie Beltrani has joined Cosette…